SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.850-8.0%2:44 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
drkaz
To: Straynut who wrote (12104)4/9/2019 2:22:16 PM
From: HardToFind1 Recommendation  Read Replies (2) of 12871
 
It looks like the press release addresses several concerns previously raised on this board:
  1. The ability to produce GLP-compliant 1 Kg batches of NV-HHV-101
  2. The rationale for NV-HHV-101's believed ability to arrest PHN pain
  3. Cidofovir's toxicity and the clinical need for a low-toxicity alternative
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext